Allergan

AGN

204.65

+1.99

+1.0%

After Hours:

203.90

-0.75

-0.4%

Please Login or Register

Login|Register FREE

Stock Price
Open: 202.50
Prev. Close: 202.66
Low/Hi: 201.42 - 209.25
52-Week: 184.50 - 256.80
Volumes
Equity: 3,895,301
90-Day Avg: 2,226,863
Option: 17,494
90-Day Avg: 10,184
Volatility
Todays Stock Vol: 39.0
20-Day (HV): 28.4
52-Week (HV): 23.9
30-Day IV: 25.9 +0.9
IV Pct Rank: 64% Moderate
Fundamental
Dividend: 10-Nov $0.70 (Est.)
Div. Yield: 1.4%
Earnings: 3-Nov (Est.)
P/E Ratio: 7.01
Market Cap: 67.8 B
Stock Type: Common
Sector: Healthcare
Industry: Drugs - Generic
Stock Type: Common | Sector: Healthcare | Industry: Drugs - Generic

AGN Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income 962,400 -2,634,800 -70,200 15,150,400
Change in Working Capital 454,900 -235,800 -426,200 459,800
Depreciation Amortization Depletion and Accretion -1,645,500 1,842,900 1,539,600 1,689,300
Deferred Taxes -766,000 -712,800 -926,800 -190,000
Other Non-Cash Activities -1,162,100 2,393,200 -271,100 -18,273,300
Total Cash from Operating Activities -3,842,600 723,300 -83,300 -1,092,400
Capital Expenditures -344,000 -379,500 -82,900 -67,700
Other Investing Cash Flow 729,800 393,700 6,808,900 17,817,800
Total Cash from Investing Activities 385,800 14,200 6,726,000 17,750,100
Dividends and Distributions -306,100 -305,800 -69,600 -69,600
Purchase or Sale of Stock 66,400 23,100 -12,283,700 -2,660,600
Purchase and Retirement of Debt -1,540,300 -1,015,900 -17,700 -6,845,400
Other Financing Cash Flow 58,800 -76,300 -89,600 -19,200
Total Cash from Financing Activities -1,721,200 -1,374,900 -12,460,600 -9,594,800
Exchange Rate Effects 5,200 6,300 -12,800 2,300
Net Change in Cash -5,172,800 -631,100 -5,830,700 7,065,200
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income 14,695,000 3,683,200 -1,630,500 -750,400
Change in Working Capital -726,500 -1,272,200 -431,900 -163,600
Depreciation Amortization Depletion and Accretion 6,657,600 7,595,300 3,922,100 1,333,400
Deferred Taxes -1,443,900 -7,380,100 -690,100 -275,000
Other Non-Cash Activities -18,041,400 1,667,600 1,073,100 1,069,800
Total Cash from Operating Activities 1,425,300 4,530,000 2,243,000 1,213,500
Capital Expenditures -333,400 -609,600 -274,700 -307,900
Other Investing Cash Flow 24,666,700 -36,511,300 -5,095,900 32,600
Total Cash from Investing Activities 24,333,300 -37,120,900 -5,370,600 -275,300
Dividends and Distributions -278,400 -208,100 0 0
Purchase or Sale of Stock -14,904,300 9,112,800 -24,200 -122,000
Purchase and Retirement of Debt -9,798,700 25,003,500 3,229,200 -792,200
Other Financing Cash Flow -140,700 -464,800 -187,500 46,900
Total Cash from Financing Activities -25,122,100 33,443,400 3,017,500 -867,300
Exchange Rate Effects -8,500 -6,500 31,100 -60,900
Net Change in Cash 628,000 846,000 -79,000 10,000